Truncated versions of human and rabbit CAP18 cathelicidins showed antibacterial activity (MIC 4-128 µg/mL) and LPS-neutralizing ability with low cytotoxicity to human cells.
MIC 4-128 µg/mLTruncated cathelicidins showed antibacterial activity across this range while remaining non-toxic to human skin cells
What the researchers found
Truncated rCap18 showed superior antimicrobial activity with lower cytotoxicity; truncated hCap18 had better LPS-binding ability; both non-toxic to human fibroblasts at MIC.
Why it matters
Shorter peptides are cheaper to manufacture and potentially safer. Having one version optimized for killing bacteria and another for neutralizing LPS toxin expands the therapeutic toolkit.
The numbers in context
MIC 4-128 ug/mL; hCap18 better LPS binding; rCap18 better antimicrobial, lower cytotoxicity; nontoxic at MIC in human fibroblasts
How the study worked
In silico peptide design; solid-phase synthesis; MIC determination; quantitative LAL (LPS-binding) assay; CD spectroscopy; MTT cytotoxicity; hemolysis assay; FE-SEM, confocal microscopy, and flow cytometry for mechanism.
Who was studied
Truncated rabbit (rCap18) and human (hCap18) CAP18 peptides tested against bacteria and human cells
What this study cannot tell us
In vitro only; limited bacterial panel tested; truncation may alter in vivo stability; no animal infection models; MIC range (4-128 µg/mL) is broad.
How to read the evidence
Moderate — comprehensive in vitro characterization with multiple mechanism-of-action assays, but no in vivo data.
When this study was published
Published in 2020; cathelicidin-derived peptide engineering continues to advance.
The bigger picture
Cathelicidins are among the most studied human AMPs. Optimizing shorter fragments for specific functions (antibiotic vs anti-endotoxin) is a practical approach to AMP drug development.
Questions still open
- Can rCap18 be further optimized for lower MIC values?
- Would hCap18 be effective as a sepsis treatment for LPS neutralization?
- How stable are these truncated peptides in biological fluids?
Common questions
Why make shorter versions of natural antimicrobial peptides?
What is LPS and why neutralize it?
Read the original research
Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.
Probiotics and antimicrobial proteins, 12(4), 1582-1593
Citation
Madanchi, Hamid; Ebrahimi Kiasari, Ramin; Seyed Mousavi, Seyed Javad; Johari, Behrooz; Shabani, Ali Akbar; Sardari, Soroush. (2020). Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.. Probiotics and antimicrobial proteins, 12(4), 1582-1593. https://doi.org/10.1007/s12602-020-09648-5